Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11261200
APP PUB NO 20190276478A1
SERIAL NO

16335326

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of tuberculosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC40 WALL STREET NEW YORK NY 10005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fotouhi, Nader Basking Ridge, US 34 353
Kaneko, Takushi Guilford, US 78 1082

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 1, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 1, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 1, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00